Discover the Future of Breast Cancer Cryoablation
Are you ready to revolutionize breast cancer care? Join IceCure at the European Society of Breast Imaging (EUSOBI) Congress 2025 in Aberdeen, Scotland, from September 25–27.
Experience firsthand the “frrreeeeddddooommm” of choice with breast cryoablation and connect with leading experts, attend exclusive workshops, and learning about the latest in breast cryoablation research.
Event Highlights
- Visit Us at Booth M18. Meet the IceCure team and experience live demonstrations of our liquid nitrogen-based ProSense™ Cryoablation System
- Exclusive IceCure Workshop – Unlocking De-Escalation of Care: Cryoablation for Breast Cancer. Sign up for our workshop on Friday, September 26, from 11:30 AM – 12:30 PM BST. Renowned speakers Dr. Frederica Di Naro and Dr. Lucia Grana-Lopez will provide an in-depth examination of cryoablation for the destruction of breast cancer tumors, with a particular focus on the use of IceCure’s Liquid Nitrogen (LN2) based ProSense™ System. Limited to 50 participants – sign up here to register!
- Focus Session Presentations. During EUSOBI’s focus session “Update in HRL and imaged guided therapy,” Dr. Frederica Di Naro and Dr. Sophia Elisabeth Baldi Giorgi of Careggi Hospital in Florence will present their abstracts on breast cancer cryoablation. The will take place on Saturday, September 27, from 11:30 AM – 12:45 PM.
- A-445 Efficacy of percutaneous Cryoablation for local control of Invasive Breast Cancer: assessment of tumor response using RECIST 1.1 Criteria in comparison with hormone therapy S.E. Baldi Giorgi, Florence/IT
- A-441 Comparing Non-Surgical Approaches in Hormone Receptor Positive Breast Cancer: Cryoablation Alone, Cryoablation Plus Hormone Therapy, and Hormone Therapy Alone F. Di Naro, Florence/IT
- More Expert Insights on Breast Cancer Cryoablation in the EUSOBI Scientific Program. Additional abstracts will be presented by Dr. Francesca Pugliese and Prof. Levent Çelik, MD.
Explore the EUSOBI full scientific program and focus sessions to best plan your Congress experience.
Secure Your Spots!
- Limited Workshop Passes: Planning to attend? Contact us now to reserve your seat. Availability is limited!
- Don’t Miss the Evening Event: Join the IceCure Team in full Scottish regalia for EUSOBI’s evening celebration on Friday, September 26. Additional costs apply – sign up today!
Register Now for EUSOBI 2025 and be part of the innovation in breast cancer care!
*The breast cancer indication for the ProSense® System is currently under review by the FDA and has not yet received marketing clearance in the US. ProSense™ is cleared for the treatment of breast cancer in the EU and other select markets. Clinical indications vary by region, please contact us for additional details.